[1]
Kirsch, B., Armas, D. and Chadha, D. 2020. A Four-Way, Cross-Over Design, Randomized, Double-Blinded, Placebo-&Active-Controlled Study for the Evaluation of the Effect of a Supratherapeutic Dose of Sofpironium Bromide Gel, 15% Applied Topically on the QT/QTc Intervals in Adult Healthy Volunteers. SKIN The Journal of Cutaneous Medicine. 4, 6 (Oct. 2020), s109. DOI:https://doi.org/10.25251/skin.4.supp.109.